Outline

About consolidated presence of the life sciences field in Osaka.

While leveraging the strength of Osaka, which is the consolidated presence of life science related companies such as pharmaceutical companies and bio venture companies, as well as excellent research institutions such as Osaka University, National Institutes of Biomedical Innovation, Health and Nutrition, and National Cerebral and Cardiovascular Center, various activities are undertaken in Osaka with all-Osaka industry, academia, and government collaboration.

An example the major universities and research institutions related to life science in Osaka.
1 Osaka University

1-1 Yamadaoka, Suita-shi

2 Osaka Prefecture University

1-1 Gakuencho, Naka-ku, Sakai-shi

3 Osaka City University

3-3-138 Sugimoto, Sumiyoshi-ku, Osaka-shi

4 National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)

7-6-8 Saito-Azaki, Ibaraki-shi

5 RIKEN Center for Biosystems Dynamics Research (BDR)

6-2-3 Furuedai, Suita-shi

6 National Cerebral and Cardiovascular Center (NCVC)

5-7-1 Fujishirodai, Suita-shi

7 Center for Information and Neural Networks (CiNet)

1-4 Yamadaoka, Suita-shi

8 Osaka Research Institute of Industrial Science and Technology (ORIST)

2-7-1 Ayumino, Izumi-shi

9 AIST Kansai, National Institute of Advanced Industrial Science and Technology (AIST)

1-8-31 Midorigaoka, Ikeda-shi

10 Japan Agency for Medical Research and Development (AMED) Department of Innovative Drug Discovery and Development

3-1 Ofukacho, Kita-ku, Osaka-shi

11 Pharmaceuticals and Medical Devices Agency (PMDA) Kansai Branch

3-1 Ofukacho, Kita-ku, Osaka-shi

大阪府内のライフサイエンス関連機関の分布図です。

Consolidated presence of pharmaceutical companies

There are more than 300 pharmaceutical companies in Osaka city, especially in Dosho-machi neighborhood.
Its history dates back to the Edo period. This area used to value “pharmacopoeia” which is the source of medicine and it has monopoly on the distribution of medicines. Therefore, it was called the “town of pharmaceutical ” where this business flourished.
Even after 350 years ago, the headquarters of major pharmaceutical companies of Japan such as Shionogi & Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Sumitomo Dainippon Pharma Co., Ltd., and Takeda Pharmaceutical Co., Ltd. are in Osaka. Osaka Prefecture's pharmaceutical production amount is at the top in the whole country (from the “Annual Statistics of Production by Pharmaceutical Industry (2010)" published by the Health Policy Bureau, Ministry of Health, Labor and Welfare). In this manner, this industry supports the economy of Osaka and it is one of the biggest industrial hubs leading the pharmaceutical industry of Japan.

Major pharmaceutical company's location

History of Osaka's life science

History
Edo Period

Osaka, in particular the neighborhood of Dosho-machi neighborhood had a monopoly on the distribution of medicines and it was referred to as a “town of pharmaceutical”.

Around 1975

Osaka University President Yamamura (at that time) announced the concept of making “North Osaka a base of life science and developing bio hills”.

July 1977

National Cardiovascular Center (currently National Cerebral and Cardiovascular Center) (Suita City) was established

July 1990

Senri Life Science Foundation (currently Public Interest Incorporated Foundation Senri Life Science Foundation) was established.

April 1993

Osaka University School of Medicine and Hospital relocated from Nakanoshima in Osaka City to the current location (Suita Campus) that was newly constructed. It was integrated with the Research Institute for Microbial Devices Hospital.

August 2001

“Formation of the international base of life science in Osaka area” was decided as a project.

July 2002

Saito Biomedical Cluster Concept” was adopted as the "Intellectual cluster creation project" by the Ministry of Education, Culture, Sports, Science and Technology.

April 2005

National Institutes of Biomedical Innovation (currently National Institutes of Biomedical Innovation, Health and Nutrition) was established (Saito, Ibaraki City)

June 2007

Certified for regional innovation cluster program (in the beginning, selected for Ministry of Education, Culture, Sports, Science and Technology Intellectual Cluster Creation Project (Phase II))

September 2008

Osaka Bio Headquarters organization structure was built. Office was set up in Senri Life Science Center Building

“Osaka Bio Strategy" was formulated at the" Osaka Bio Strategy Promotion Council" organized by Industry, Academia and Government (renewed every fiscal year)

December 2011

Designated as Kansai Innovation International Strategy Special Zone (Life Innovation)

October 2013

Pharmaceuticals and Medical Devices Agency(PMDA)Kansai Branch was established

May 2014

The Kansai area is designated as a national strategy special zone as a medical innovation base

November 2014

Business operator of all zones of Saito Life Science Park was finalized

April 2015

Japan Agency for Medical Research and Development (AMED) Department of Innovative Drug Discovery and Development West Japan head office was established

July 2015

Name of Suita switching yard and surrounding area (medical cluster) where National Cerebral and Cardiovascular Center would relocate is decided as “Northern Osaka Healthcare City (popularly referred to as Kento)

June 2016

Expanded the functions of Pharmaceuticals and Medical Devices Agency (PMDA) Kansai Branch (so that it can offer various types of counseling regarding pharmaceutical affairs)

March 2018

With the completion of "Osaka Bio Strategy", we summarize initiatives for 10 years.

“Health and medical industries" is positioned as a field to newly emphasize "Osaka growth strategy”, and set up "Global cluster formation" of that industry as a direction to aim.

April 2018

Established “Osaka Health and Medical Organization Meeting of responsible person” which consists of responsible person of practical affairs of Osaka Bio Strategy Promotion Council.